Published in Diabetes on November 01, 1969
Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J Clin Invest (1999) 1.70
Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J Clin Invest (1982) 1.53
Exceptionally low blood glucose response to dried beans: comparison with other carbohydrate foods. Br Med J (1980) 1.19
Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest (1990) 0.93
Glucose and insulin secretory response patterns following diet and tolazamide therapy in diabetes. Br Med J (1970) 0.85
Abnormal regulation of carbohydrate metabolism in primary gout. Ann Rheum Dis (1974) 0.79
Hormones and lipid metabolism. Postgrad Med J (1972) 0.78
Nutritional and endocrine factors influencing plasma triglyceride metabolism. Biochem J (1971) 0.75
Secondary hyperlipidaemia. J Clin Pathol Suppl (Assoc Clin Pathol) (1973) 0.75
Lipid synthesis from the liver in patients with psoriasis. Arch Dermatol Res (1980) 0.75
Classification of lipoproteins and lipoprotein disorders. J Clin Pathol Suppl (Assoc Clin Pathol) (1973) 0.75
Endogenous hypertriglyceridemia in type II hyperlipoproteinemia. Am J Hum Genet (1970) 0.75
Classification of hyperlipidaemias. Proc R Soc Med (1971) 0.75
The role of carbohydrate and oral agents in the treatment of diabetes mellitus. Calif Med (1973) 0.75
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta (1972) 9.02
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 6.51
Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ (1970) 5.58
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 4.09
The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J Clin Invest (1972) 3.43
Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation (1974) 3.29
Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. JAMA (1994) 3.11
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 3.09
Studies of the proteins in human plasma very low density lipoproteins. J Biol Chem (1969) 2.98
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 2.86
Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol (1997) 2.59
Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. Circulation (1984) 2.41
The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae. Proc Natl Acad Sci U S A (1966) 2.32
Study of the genetic transmission of hypercholesterolemia and hypertriglyceridemia in a 195 member kindred. Ann Hum Genet (1975) 2.32
Pathogenesis and management of lipoprotein disorders. N Engl J Med (1985) 2.31
A specific apoprotein activator for lipoprotein lipase. Biochem Biophys Res Commun (1970) 2.24
Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia. J Lab Clin Med (1976) 2.20
Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism (1994) 2.04
Metabolic consequences of exposure to polychlorinated biphenyls (PCB) in sewage sludge. Am J Epidemiol (1980) 1.96
The Collaborative Lipid Research Clinics Family Study: biological and cultural determinants of familial resemblance for plasma lipids and lipoproteins. Genet Epidemiol (1985) 1.95
Lipoprotein metabolism. Adv Lipid Res (1975) 1.90
Total inhibition of hepatic beta-lipoprotein production in the rat by orotic acid. J Biol Chem (1967) 1.79
Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. N Engl J Med (1986) 1.70
Declining mortality in coronary heart disease. Arteriosclerosis (1982) 1.70
Determinants of high-density lipoprotein cholesterol in blacks and whites: the second National Health and Nutrition Examination Survey. Am Heart J (1984) 1.69
Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. J Clin Invest (1974) 1.66
The Cincinnati Lipid Research Clinic family study: cultural and biological determinants of lipids and lipoprotein concentrations. Am J Hum Genet (1982) 1.64
Limitations of the electrocardiographic response to exercise in predicting coronary-artery disease. N Engl J Med (1975) 1.61
On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein. Biochim Biophys Acta (1973) 1.59
Blood lead levels and dietary calcium intake in 1- to 11-year-old children: the Second National Health and Nutrition Examination Survey, 1976 to 1980. Pediatrics (1986) 1.57
Public cholesterol screening: motivation for participation, follow-up outcome, self-knowledge, and coronary heart disease risk factor intervention. J Lab Clin Med (1989) 1.54
A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques. J Clin Invest (1969) 1.54
The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. Circulation (1984) 1.54
High density lipoprotein metabolism in man. J Clin Invest (1977) 1.53
Progress in prevention of cardiovascular disease. Prev Med (1978) 1.53
Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects. J Lipid Res (1978) 1.53
Cardiovascular pathology in hyperlipoproteinemia. Anatomic observations in 42 necropsy patients with normal or abnormal serum lipoprotein patterns. Am J Cardiol (1973) 1.52
Quantitative analysis of cholesterol in 5 to 20 microliter of plasma. J Lipid Res (1974) 1.52
Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood. J Clin Invest (1974) 1.50
Lipoprotein apoprotein metabolism. J Lipid Res (1978) 1.48
The nature of pre beta (very low density) lipoproteins. J Clin Invest (1966) 1.48
Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease. Am J Cardiol (1969) 1.45
Production of beta-lipoprotein by intestine in the rat. J Biol Chem (1968) 1.45
Postmenopausal cyclic estrogen-progestin therapy lowers lipoprotein[a]. J Lab Clin Med (1994) 1.44
Comparison of the triglyceride lipase of liver, adipose tissue, and postheparin plasma. J Lipid Res (1972) 1.44
Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc Natl Acad Sci U S A (1999) 1.42
Current therapy for hypercholesterolemia. JAMA (1989) 1.42
On the protein defect in abetalipoproteinemia. N Engl J Med (1971) 1.40
Acute muscular syndrome associated with administration of clofibrate. N Engl J Med (1968) 1.40
Estrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia. Metabolism (1972) 1.39
Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man. J Clin Invest (1968) 1.38
Metabolic and health consequences of occupational exposure to polychlorinated biphenyls. Br J Ind Med (1982) 1.35
Biosynthesis of lymph and plasma lipoprotein apoproteins by isolated perfused rat liver and intestine. J Lipid Res (1973) 1.35
Suppression of amylase activity by hypertriglyceridemia. JAMA (1973) 1.35
Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins. Circ Res (1973) 1.33
Familial hyper-alpha-lipoproteinemia: studies in eighteen kindreds. Metabolism (1975) 1.32
Neonatal diagnosis of familial type-II hyperlipoproteinaemia. Lancet (1973) 1.32
Enzyme deficiency in cholesteryl ester storage idisease. J Clin Invest (1972) 1.32
Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. Metabolism (1984) 1.29
Further separation of the apoproteins of the human plasma very low density lipoproteins. Biochim Biophys Acta (1970) 1.28
Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc Natl Acad Sci U S A (2000) 1.26
Glycolipids and other lipid constituents of normal human liver. J Lipid Res (1970) 1.26
The pathology of Tangier disease. A light and electron microscopic study. Am J Pathol (1975) 1.26
Electron microscopic study on reassembly of plasma high density apoprotein with various lipids. Biochim Biophys Acta (1971) 1.24
The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. Ann Intern Med (1975) 1.24
Neonatal familial type II hyperlipoproteinemia: cord blood cholesterol in 1800 births. Metabolism (1971) 1.23
Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. N Engl J Med (1978) 1.23
Diagnosis and management of hyperlipoproteinemia. Am J Cardiol (1968) 1.23
The decline in cardiovascular disease mortality. Annu Rev Public Health (1981) 1.22
The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocrinol Metab (1983) 1.22
Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. JAMA (2000) 1.21
Mutants, hyperlipoproteinaemia, and coronary artery disease. Br Med J (1971) 1.21
Lipid and lipoprotein tracking in 108 children over a four-year period. Pediatrics (1979) 1.20
Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men. Lancet (1987) 1.20
Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2. J Lipid Res (1982) 1.19
Plasma cholesterol and triglyceride levels in 6,775 school children, ages 6--17. Metabolism (1977) 1.18
Tangier disease (familial high density lipoprotein deficiency). Clinical and genetic features in two adults. Am J Med (1965) 1.17
It's time to be practical. Circulation (1975) 1.16
Responses of normal children and young adults to controlled bicycle exercise. Circulation (1980) 1.16